Literature DB >> 25068620

Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.

D Rebecca Prevots1, Jennifer Adjemian, Aisling G Fernandez, Michael R Knowles, Kenneth N Olivier.   

Abstract

RATIONALE: Persons with cystic fibrosis are at high risk of pulmonary nontuberculous mycobacterial infection, with a national prevalence estimated at 13%. The risk of nontuberculous mycobacteria associated with specific environmental exposures, and the correlation with climatic conditions in this population has not been described.
OBJECTIVES: To describe the association of pulmonary nontuberculous mycobacteria with individual exposures to water and soil aerosols, and the population associations of these infections with climatic factors.
METHODS: We conducted a nested case-control study within a cohort study of pulmonary nontuberculous mycobacteria prevalence at 21 geographically diverse national cystic fibrosis centers. Incident nontuberculous mycobacterial infection cases (at least one prior negative culture followed by one positive culture) were age- and sex-matched to culture-negative controls. Exposures to water and soil were assessed by administering a standardized questionnaire. Cohort prevalence at each of the 21 centers was correlated with climatic conditions in the same area through linear regression modeling.
MEASUREMENTS AND MAIN RESULTS: Overall, 48 cases and 85 control subjects were enrolled. Indoor swimming was associated with incident infection (adjusted odds ratio, 5.9, 95% confidence interval, 1.3-26.1), although only nine cases (19%) and five control subjects (6%) reported indoor swimming in the 4 months prior to infection. Exposure to showering and municipal water supply was common among both cases and control subjects: 77% of cases and 76% of control subjects reported showering at least daily. In linear regression, average annual atmospheric water vapor content was significantly predictive of center prevalence (P = 0.0019), with R(2) = 0.40.
CONCLUSIONS: Atmospheric conditions explain more of the variation in disease prevalence than individual behaviors. The risk of specific exposures may vary by geographic region due to differences in conditions favoring mycobacterial growth and survival. However, because exposure to these organisms is ubiquitous and behaviors are similar among persons with and without pulmonary nontuberculous mycobacteria, genetic susceptibility beyond cystic fibrosis is likely to be important for disease development. Common individual risk factors in high-risk populations remain to be identified.

Entities:  

Keywords:  cystic fibrosis; environmental; epidemiology; nontuberculous mycobacteria

Mesh:

Year:  2014        PMID: 25068620      PMCID: PMC4214058          DOI: 10.1513/AnnalsATS.201404-184OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  20 in total

1.  Occurrence of nontuberculous mycobacteria in environmental samples.

Authors:  T C Covert; M R Rodgers; A L Reyes; G N Stelma
Journal:  Appl Environ Microbiol       Date:  1999-06       Impact factor: 4.792

2.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

3.  Nontuberculous mycobacteria in aerosol droplets and bulk water samples from therapy pools and hot tubs.

Authors:  Craig S Glazer; John W Martyny; Ben Lee; Tracy L Sanchez; Tricia M Sells; Lee S Newman; James Murphy; Leonid Heifets; Cecile S Rose
Journal:  J Occup Environ Hyg       Date:  2007-11       Impact factor: 2.155

4.  Genetic modifiers of lung disease in cystic fibrosis.

Authors:  Mitchell L Drumm; Michael W Konstan; Mark D Schluchter; Allison Handler; Rhonda Pace; Fei Zou; Maimoona Zariwala; David Fargo; Airong Xu; John M Dunn; Rebecca J Darrah; Ruslan Dorfman; Andrew J Sandford; Mary Corey; Julian Zielenski; Peter Durie; Katrina Goddard; James R Yankaskas; Fred A Wright; Michael R Knowles
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

5.  Mycobacteria in semi-public swimming-pools and whirlpools.

Authors:  A H Havelaar; L G Berwald; D G Groothuis; J G Baas
Journal:  Zentralbl Bakteriol Mikrobiol Hyg B       Date:  1985-05

Review 6.  Modifier genes in Mendelian disorders: the example of cystic fibrosis.

Authors:  Garry R Cutting
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

7.  Environmental risk factors for infection with Mycobacterium avium complex.

Authors:  Carrie Reed; C Fordham von Reyn; Sandra Chamblee; Tedd V Ellerbrock; Johnny W Johnson; Bryan J Marsh; Linda S Johnson; Robert J Trenschel; C Robert Horsburgh
Journal:  Am J Epidemiol       Date:  2006-05-04       Impact factor: 4.897

8.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

Authors:  Richard D Kim; David E Greenberg; Mary E Ehrmantraut; Shireen V Guide; Li Ding; Yvonne Shea; Margaret R Brown; Milica Chernick; Wendy K Steagall; Connie G Glasgow; JingPing Lin; Clara Jolley; Lynn Sorbara; Mark Raffeld; Suvimol Hill; Nilo Avila; Vandana Sachdev; Lisa A Barnhart; Victoria L Anderson; Reginald Claypool; Dianne M Hilligoss; Mary Garofalo; Alan Fitzgerald; Sandra Anaya-O'Brien; Dirk Darnell; Rosamma DeCastro; Heather M Menning; Stacy M Ricklefs; Stephen F Porcella; Kenneth N Olivier; Joel Moss; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

9.  Study on the relationship between isolation of mycobacteria and classical microbiological and chemical indicators of water quality in swimming pools.

Authors:  M Dailloux; P Hartemann; J Beurey
Journal:  Zentralbl Bakteriol Mikrobiol Hyg B       Date:  1980

10.  Opportunistic pathogens enriched in showerhead biofilms.

Authors:  Leah M Feazel; Laura K Baumgartner; Kristen L Peterson; Daniel N Frank; J Kirk Harris; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-14       Impact factor: 11.205

View more
  17 in total

1.  Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Authors:  Eva P Szymanski; Janice M Leung; Cedar J Fowler; Carissa Haney; Amy P Hsu; Fei Chen; Priya Duggal; Andrew J Oler; Ryan McCormack; Eckhard Podack; Rebecca A Drummond; Michail S Lionakis; Sarah K Browne; D Rebecca Prevots; Michael Knowles; Gary Cutting; Xinyue Liu; Scott E Devine; Claire M Fraser; Hervé Tettelin; Kenneth N Olivier; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

2.  A Geospatial Epidemiologic Analysis of Nontuberculous Mycobacterial Infection: An Ecological Study in Colorado.

Authors:  Ettie M Lipner; David Knox; Joshua French; Jordan Rudman; Michael Strong; James L Crooks
Journal:  Ann Am Thorac Soc       Date:  2017-10

Review 3.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Authors:  D Rebecca Prevots; Theodore K Marras
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

4.  Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.

Authors:  Paul Breen; Madsen Zimbric; Kristopher Opron; Lindsay J Caverly
Journal:  mSphere       Date:  2022-04-28       Impact factor: 5.029

5.  Identification of nontuberculous mycobacteria isolated from household showerheads of patients with nontuberculous mycobacteria.

Authors:  Ji Yeon Choi; Bo Ra Sim; Youngmok Park; Seung Hyun Yong; Sung Jae Shin; Young Ae Kang
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996

6.  The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Authors:  Sara E Strollo; Jennifer Adjemian; Michael K Adjemian; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2015-10

7.  Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.

Authors:  Nathalie Coolen-Allou; Thomas Touron; Olivier Belmonte; Virgile Gazaille; Michel Andre; Jérôme Allyn; Sandrine Picot; Annabelle Payet; Nicolas Veziris
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

8.  Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients.

Authors:  Davide Caimmi; Nicolas Martocq; Delphine Trioleyre; Catherine Guinet; Sylvain Godreuil; Thomas Daniel; Raphael Chiron
Journal:  Open Forum Infect Dis       Date:  2018-02-17       Impact factor: 3.835

Review 9.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

10.  Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration.

Authors:  Makoto M Jones; Kevin L Winthrop; Scott D Nelson; Scott L Duvall; Olga V Patterson; Kevin E Nechodom; Kimberly E Findley; Lewis J Radonovich; Matthew H Samore; Kevin P Fennelly
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.